New Indications and Dosage Forms for 2002

See also: New Drug Approvals for 2002

August 29, 2002

Lexapro Approved as Maintenance Treatment for Major Depressive Disorder

December 2, 2002

Lexapro Oral Solution Formulation Provides New Option for Depressed Patients

December 18, 2002

Lexapro Receives FDA Approval for the Treatment of Generalized Anxiety Disorder

December 20, 2002

Gleevec Approved for First Line Treatment of Chronic Myeloid Leukemia (CML)

New indications and dosage forms archive

Recently Approved

Brinsupri
Brinsupri (brensocatib) is a dipeptidyl peptidase 1 inhibitor for the treatment...
Hernexeos
Hernexeos (zongertinib) is a kinase inhibitor used for the treatment of...
Modeyso
Modeyso (dordaviprone) is a protease activator used for the treatment of...

More drug approvals